Stanford Synchrotron Radiation Lightsource (SSRL)
Researchers hope to hijack a natural process called RNA interference to block the production of proteins linked to disease and treat medical conditions for which conventional drugs do not work, including cancer, heart disease, HIV and Parkinson’s disease.
Guarav "Gino" Giri, who this summer completed his doctoral work in chemical engineering at Stanford, has been selected to receive this year's Melvin P. Klein Scientific Development Award for his pioneering work aimed at understanding and improving organic semiconductor performance and developing new production methods.
In a new state-of-the-art lab at SLAC National Accelerator Laboratory, components of ribosomes – tiny biological machines that make new proteins and play a vital role in gene expression and antibiotic treatments – form crystals in a liquid solution.
Signs at the lab's entryway warn of the potential for contamination – these delicate samples can be damaged by human touch, a sneeze or a dust particle.
Last Saturday marked the 40th anniversary of an historic event: In 1973, a team of research pioneers extracted hard X-rays for the first time from SLAC's SPEAR accelerator. Like X-rays from an X-ray tube, the radiation generated by SPEAR can deeply penetrate a large variety of materials and probe their inner structures. However, SPEAR's X-rays are significantly more intense and unlock the possibility for brand new science.